These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 9262671)

  • 1. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995).
    Van Liew CH; Greco DS; Salman MD
    J Am Vet Med Assoc; 1997 Aug; 211(3):322-5. PubMed ID: 9262671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1986 Dec; 189(12):1562-6. PubMed ID: 3025143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of hyperadrenocorticism in dogs.
    Peterson ME
    Clin Tech Small Anim Pract; 2007 Feb; 22(1):2-11. PubMed ID: 17542191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs.
    Kaplan AJ; Peterson ME; Kemppainen RJ
    J Am Vet Med Assoc; 1995 Aug; 207(4):445-51. PubMed ID: 7591942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1985 Jul; 187(1):49-53. PubMed ID: 2991177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stages of hyperadrenocorticism: response of hyperadrenocorticoid dogs to the combined dexamethasone suppression/ACTH stimulation test.
    Eiler H; Oliver JW; Legendre AM
    J Am Vet Med Assoc; 1984 Aug; 185(3):289-94. PubMed ID: 6088452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995).
    Greco DS; Peterson ME; Davidson AP; Feldman EC; Komurek K
    J Am Vet Med Assoc; 1999 May; 214(9):1349-53. PubMed ID: 10319177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Angles JM; Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
    Mack RE; Feldman EC
    J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1983 Mar; 182(5):506-10. PubMed ID: 6300008
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism.
    Kerl ME; Peterson ME; Wallace MS; Melián C; Kemppainen RJ
    J Am Vet Med Assoc; 1999 May; 214(10):1497-501. PubMed ID: 10340075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
    Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
    Ford SL; Feldman EC; Nelson RW
    J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia.
    Norman EJ; Thompson H; Mooney CT
    Vet Rec; 1999 May; 144(20):551-4. PubMed ID: 10371012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
    Batista DL; Riar J; Keil M; Stratakis CA
    Pediatrics; 2007 Sep; 120(3):e575-86. PubMed ID: 17698579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia.
    Peterson ME; Gilbertson SR; Drucker WD
    J Am Vet Med Assoc; 1982 Mar; 180(5):542-4. PubMed ID: 6277837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990).
    Kipperman BS; Feldman EC; Dybdal NO; Nelson RW
    J Am Vet Med Assoc; 1992 Sep; 201(5):762-7. PubMed ID: 1328121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.